Parker Waichman LLP Responds to FDA Decision Requiring Vision Loss Warnings for Ozempic, Wegovy, Mounjaro, Zepbound, and Other GLP-1 Drugs
Landmark FDA Action Requires New Warnings About NAION, a Serious Eye Condition That Can Cause Sudden and Permanent Vision Loss PORT WASHINGTON, N.Y., Nov. 10, 2026 /PRNewswire/ -- Parker Waichman LLP, a national law firm representing individuals who have suffered serious injuries...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 133 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.